In 2024, the US Food and Drug Administration (FDA) approved 19 innovative medications and vaccines that are expected to make a significant impact on various health conditions. These include “first-in-class” medications and vaccines prioritized for their potential to improve human health.
Approved for various uses, these medications include treatments for high blood pressure, severe allergic reactions, chronic obstructive pulmonary disease (COPD), and more. Notable examples include Wegovy, a weight-loss medication also approved for cardiovascular risk reduction; Tryvio, a new treatment for high blood pressure; and Neffy, the first nasal spray for severe allergic reactions.
According to GoodRx, a digital health care platform, these approvals are expected to have a significant clinical impact on patients in need. The company prioritized medications with effectiveness or safety data that represent a notable advantage over existing treatments.
“The number of lives touched or the expected degree of impact for future medication recipients” was the primary consideration for this list. Additionally, medications that make treatment more convenient for consumers were also included.
These FDA approvals demonstrate significant advancements in medicine, offering new hope for patients with various health conditions.
Source: https://www.foxnews.com/health/drug-approvals-2024-big-clinical-impact-according-goodrx